# Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

> **NCT04160455** · — · RECRUITING · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 180 (estimated)

## Conditions studied

- Autophagy
- Galectins
- HIV Infections
- Highly Active Antiretroviral Therapy

## Interventions

- **BIOLOGICAL:** expression of a panel

## Key facts

- **NCT ID:** NCT04160455
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-07
- **Primary completion:** 2029-11-07
- **Final completion:** 2039-11-07
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160455, "Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04160455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*